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Abstract 41 
Jasonia glutinosa (L.) DC., known as rock tea (RT), is traditionally used in Spain as a digestive due to its 42 
beneficial properties in bowel disorders. The pharmacological nature of these properties has not been 43 
established yet. The aim of this work was to evaluate the therapeutic utility of RT in experimental colitis 44 
and to identify chemical constituents with anti-inflammatory and/or anti-oxidative properties. 45 
RT extract was prepared with ethanol in a Soxhlet apparatus and analysed by HPLC-DAD. Superoxide 46 
radical scavenging properties, xanthine oxidase and lipoxygenase (5-LOX) inhibitory activity, and 47 
capability to lower nitric oxide (NO) and tumour necrosis factor α (TNF-α) levels were measured in cell-48 
free and cell-based assays. In the 2.5%-dextran-sodium sulphate (DSS) injury-repair model of ulcerative 49 
colitis (UC), mice were daily treated with sulfasalazine (SSZ, as reference drug, 100 mg/kg bw), RT (5, 25 50 
and 50 mg/kg bw, p.o.), or vehicle over 20-days. Colitis was scored daily. Colon samples were 51 
macroscopically and histopathologically examined. Protein levels of myeloperoxidase (MPO), interleukins 52 
6, and 10 (IL-6, IL-10), inducible NO synthase (iNOS), and cyclooxygenase-2 (COX-2) were studied as 53 
markers of oxidative stress and inflammatory activity. The integrity of the apical epithelial layer was 54 
assessed by immunofluorescence staining of zonula ocludens-1 (ZO-1). Finally, intestinal contractility was 55 
also evaluated by isometric myography. 56 
Fifteen phenolic compounds and three pigments were identified and quantified, of which caffeoylquinic 57 
acids, and the flavonoid, quercetin-3-O-galactoside, were the most abundant. RT extract significantly 58 
scavenged superoxide radicals, inhibited 5-LOX activity, and lowered NO and TNF-α levels. DSS-treated 59 
mice receiving RT scored clinically lower than controls during the first 3-days of DSS-treatment and during 60 
the recovery period. SSZ was less effective than RT. Anatomical and histological examination of colon 61 
samples revealed that RT significantly prevented shortening and thickening, and lowered the macroscopic 62 
damage score. RT also significantly prevented the increase of MPO activity, IL-6 levels, iNOS and COX-63 
2 expression, the loss of ZO-1 apical expression, and normalized contractility disturbances. 64 
In conclusion, daily administration of RT showed therapeutic properties in the DSS-model of UC. The 65 
benefits of RT can likely be attributed to its anti-inflammatory and antioxidant phenolic and flavonoid 66 
constituents. 67 
 68 
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 81 
1. Introduction 82 
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD), which is characterized by inflammation of 83 
the intestinal wall and ulcers in colon and rectum. The prevalence and incidence of UC is increasing over 84 
the years (Molodecky et al. 2012). The classical clinical features are weight loss, bloody stool, abdominal 85 
pain and intestinal motility disorders as diarrhoea or tenesmus. The aetiology is not fully understood, 86 
although genetic and environmental factors have been proposed (Baumgart and Carding 2007; Baumgart 87 
and Sandborn 2007; Danese and Fiocchi 2011; Low et al. 2013). The main histopathological feature of UC 88 
is the damage of the intestinal mucosa (epithelial layer), resulting in a loss of the defensive epithelial barrier, 89 
leading to increased permeability and an inflammatory response (Silva et al. 2016). Under inflammatory 90 
conditions, the morphology and structure of interstitial cells of Cajal can be affected, producing changes in 91 
the gastrointestinal motility (Dai et al. 2017; Won et al. 2006). In addition, dysmotility can increase the 92 
overgrowth of bacteria, the release of toxic products as well as their translocation through the barrier of the 93 
intestinal mucosa, increasing the severity of the condition. 94 
Currently, drug therapies for UC based on salicylates and corticosteroids are not satisfactory, can be costly 95 
and may have important side effects. Therefore, there is a clinical need for new therapeutic strategies that 96 
may also derive from traditional herbal medicine (Low et al. 2013; Zheng et al. 2017).   97 
 98 
Jasonia glutinosa (L.) DC. (Compositae), popularly known as rock tea (RT), is a medicinal plant species 99 
of the Iberian Peninsula and southern France. Infusions and decoctions are described as digestives and are 100 
used as substitutes for coffee or tea after meals due to the fact that this medicinal plant has been reported to 101 
relieve common gastrointestinal disturbances, such as diarrhoea or abdominal pain (Alarcόn et al. 2015; 102 
Pardo Santayana and Morales 2004). Other traditional uses include the treatment of appendicitis, respiratory 103 
diseases and as analgesic, antiemetic or antidepressant medicinal plant (Akerreta et al. 2007; Pardo 104 
Santayana and Morales 2004).  105 
Although certain studies with J. glutinosa have shown antioxidant (López et al. 2008), anti-inflammatory 106 
(Bermejo et al. 2002), antimicrobial (Villaescusa-Castillo et al. 2000; Villaescusa et al. 1996), 107 
antihypertensive (Valero et al. 2015) and spasmolytic properties (Castro et al. 2016), there is still a 108 
considerable lack of in-vivo studies supporting these traditional uses. In fact, studies involving the effects 109 
of this medicinal plant on the clinical symptoms of intestinal inflammation have never been performed or 110 
published. To the best of our knowledge, most of the existing studies concerning the chemical composition 111 
of J. glutinosa focus on its volatile composition (Valero et al. 2013). Although previous works report the 112 
presence of some flavonoids (Rubio et al. 1995; Villaescusa et al. 1995), there is a gap in the biologically-113 
relevant metabolites knowledge of this plant. Therefore, we here aim to examine whether oral 114 
administration of RT extract is beneficial in the standard dextran sodium sulphate (DSS)-model of colitis. 115 
So, we evaluated the efficacy of RT to ameliorate the clinical progression of colitis, the microscopic and 116 
macroscopic colonic damage, loss of intestinal barrier and motility disturbances as well as its antioxidant 117 
and anti-inflammatory properties. Phenolic and carotenoid profiles were also determined by liquid 118 
chromatography (HPLC-DAD), in an attempt to identify therapeutically active constituents. 119 
 120 
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2. Materials and Methods 121 
2.1. Standards and reagents 122 
Standards of ascorbic acid, linoleic acid, caffeic acid, quercetin, lutein, β-carotene, chlorophyll a, and 123 
chlorophyll b were purchased from Sigma-Aldrich (St. Louis, MO, USA). Quercetin-3-O-galactoside, 124 
quercetin-3-O-glucoside, kaempferol and isorhamnetin were from Extrasynthèse (Genay, France). 3-O-125 
caffeoylquinic acid, 5-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, 1,3-di-O-caffeoylquinic acid, 126 
isoferulic acid, 3,4-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid, 1,5-di-O-caffeoylquinic acid, 127 
and 4,5-dicaffeoylquinic acid were obtained from Chengdu Biopurify Phytochemicals Ltd. (Chengdu, 128 
Sichuan, China). Pheophytin a was from LGC Standards (Irvine, CA, US).  129 
Potassium dihydrogen phosphate (KH2PO4), sodium phosphate dibasic (Na2HPO4), nitrotetrazolium blue 130 
chloride (NBT), lipoxygenase (5-LOX) from Glycine max (L.) Merr. (type V-S; EC 1.13.11.12), β-131 
nicotinamide adenine dinucleotide (NADH), phenazine methosulfate (PMS), tert-butyl methyl ether 132 
(MTBE), gallic acid, xanthine, NBT, xanthine oxidase, DPPH, galantamine, ATCI, DTNB, Tris, vanillic 133 
acid, 4-aminoantipyrine, horseradish peroxidase, LPS (lipopolysaccharide from Escherichia coli serotype 134 
011:B4), RPMI Medium 1640-GlutaMAXTM-I, trypsin, penicillin G, streptomycin, dimethyl sulfoxide 135 
(DMSO), sodium nitrite (NaNO2), compounds of Griess reactive and acetylcholine were purchased from 136 
Sigma-Aldrich. HPLC grade methanol was obtained from Merck (Darmstadt, Germany) and formic acid 137 
was purchased from BDH Prolab (Dublin, Ireland). Dextran sodium sulphate (DSS) was purchased from 138 
Panreac. 139 
Water was deionized in a Milli-Q water purification system (Millipore, Bedford, MA, USA). 140 
2.2. Plant material and extraction 141 
Collection of the plant and preparation of the ethanolic extract were performed as described in Valero et 142 
al., (Valero et al. 2015) following The United Nations Convention on Biological Diversity. Samples were 143 
authenticated and a voucher specimen (ref. 001-2012) has been deposited at the Department of Pharmacy 144 
of Universidad San Jorge. Solvent (ethanol) was removed using a rotary evaporator under vacuum and 145 
samples were kept at – 20 ºC until bioassays. 146 
2.3. Phytochemical analyses  147 
2.3.1. HPLC-DAD analysis 148 
The dried ethanolic extract of J. glutinosa was reconstituted in high quality methanol and filtered with a 149 
membrane (pore size:0.45 μm) before chromatographic analysis. 150 
2.3.1.1. Phenolic compounds determination 151 
20 µL of re-dissolved and filtered extract was analysed using a Gilson HPLC-DAD unit with a Spherisorb 152 
ODS2 column (25.0 cm×0.46 cm, 5 µm particle size; Waters, Milford, MA, USA) maintained at 26 °C. 153 
The mobile phase solvents consisted of 1% (v/v) formic acid in water (eluent A) and methanol (eluent B) 154 
and a gradient program was used as follows: from 10 to 15% B (5 min), from 15 to 40% B (20 min), from 155 
40 to 55% B (25 min), from 55 to 100% B (10 min), 100% B isocratic (20 min) run at a flow rate of 0.4 156 
mL/min. Spectral data from all peaks (200-600 nm) and chromatograms (280, 320, 330 nm) were collected 157 
using an Agilent 1100 series diode array detector. Retention times and UV-vis spectra of authentic standards 158 
analysed in the same conditions were used for the identification of phenolic compounds. For quantification 159 
purposes, the extract was injected in triplicate. The amount of phenolic compounds present in the extract 160 
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was achieved from the calibration curves of the respective authentic standard analysed under the same 161 
conditions (Table 1).  162 
The linearity range of the method was assessed by building calibration curves using, at least, six different 163 
concentration levels of the analytes, according to the range of concentrations found in the sample. The limit 164 
of detection (LOD) and limit of quantification (LOQ) were determined from calibration curve data, 165 
following the formula: 166 
LOD = (3 × SD)/b 167 
LOQ = (10 × SD)/b, 168 
where SD is the residual standard deviation and b is the slope. The repeatability and reproducibility of the 169 
method were calculated in terms of intra-day and inter-day precision, respectively. Repeatability was 170 
performed by injecting the J. glutinosa extract, by the same analyst, 5 times in the same day, whereas, 171 
reproducibility was performed by injecting that same sample in triplicate during 5 consecutive days. Final 172 
results were expressed as coefficient of variation (CV, %) (Table 1). 173 
2.3.1.2. Pigments (carotenoids and chlorophylls) determination 174 
20 µL of re-dissolved and filtered ethanolic extract was analysed using a Gilson HPLC unit with a C30 175 
YMC carotenoid column 5 μm, 250 × 4.6 mm (YMC, Japan) maintained at 26 °C, following the procedure 176 
described by Amaro et al., (Amaro et al. 2015) with some modifications. The mobile phase was composed 177 
by two solvents, methanol (A) and tert-butyl methyl ether (B); elution started with 95% A and used a 178 
gradient to obtain 70% at 30 min, 50% at 50 min, 0% at 60 min, 0% isocratic at 65 min and 95% at 70 min. 179 
In this case, spectral data from all peaks (200-700 nm) and chromatograms at 450 nm were collected using 180 
an Agilent 1100 series diode array detector. The data were processed with Clarity Software, version 181 
5.04.158 (DataApex Ltd, Prague, Czech Republic). Peak purity was checked by the software contrast 182 
facilities. The extract was injected in triplicate. The amount of pigments was calculated using external 183 
calibration curves. Only the compounds, for which we had reference standards, were quantified. The 184 
linearity range, the LOD and LOQ, the repeatability and reproducibility of the method (Table 1) were 185 
determined according to the one described above. 186 
2.4. Cell-free assays 187 
2.4.1. Antioxidant activity 188 
2.4.1.1. Non-enzymatic assay 189 
According to a procedure previously documented, the NADH/PMS system was used for the generation of 190 
superoxide radicals  (Valentão et al. 2001). Due to the low solubility of the extract in the phosphate buffer 191 
(19 mM, pH 7.4), we used a non-interfering DMSO percentage (1% v/v, phosphate buffer). The remaining 192 
components were dissolved in phosphate buffer. Antiradical activity was determined 193 
spectrophotometrically at 562 nm, in a 96-well Multiskan Ascent plate reader (Thermo; electron 194 
corporation), working in kinetic mode, by monitoring the effect of extract on reduction of NBT induced by 195 
superoxide radical. Four independent assays were performed in triplicate and quercetin as positive control.  196 
2.4.1.2. Enzymatic assay 197 
The xanthine/xanthine oxidase (X/XO) system was used for the enzymatic generation of superoxide 198 
radicals (Rodríguez-Chávez et al. 2015). The assay was performed in 96-well microplates, and the mixture 199 
contained 90 μM xanthine, 16 mM Na2CO3 and 22.8 μM NBT dissolved in phosphate buffer (pH 7). Then, 200 
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30 μL of sample at different concentrations (0.0125, 0.0039, 0.0020, 0.0010, 0.0005, 0.0002, 0.0001, 201 
0.00006, 0.00003 mg/mL) and 30 μL of 168 U/L xanthine oxidase were added to start the reaction.  202 
Incubation time: 2 min at 37 °C. Absorbance was measured at 560 nm. Gallic acid was used as reference.  203 
The effect on xanthine oxidase was also evaluated by measuring the formation of uric acid from xanthine 204 
at 295 nm after 2 min. The reaction mixture contained the same components as described above in the 205 
xanthine/xanthine oxidase system but the reaction mixture did not contain 22.8 μM NBT.  206 
2.4.2. Anti-inflammatory activity 207 
2.4.2.1. 5-Lipoxygenase inhibition 208 
The inhibitory effect on 5-LOX was assessed in 96-well plates, using a procedure previously described by 209 
Barbosa et al., (Barbosa et al. 2017). A Synergy™ HT microplate reader (Biotek Instruments; Winooski, 210 
USA) was used to detect 5-LOX inhibitors at 234 nm for 3 min. 5-LOX inhibition was calculated as follows: 211 
LOX inhibitory activity (%) = 100 × [1− (mean V of sample/mean V of control)], where mean V 212 
corresponds to the mean velocity of kinetic well analysis. Six independent assays were performed in 213 
triplicate. Quercetin was used as positive control. 214 
2.5. Cell-based assays 215 
2.5.1. Cell culture conditions 216 
Murine macrophages (J774.2; The Agrifood Research and Technology Centre of Aragon; Zaragoza, Spain) 217 
were cultured in 96-well plates with Roswell Park Memorial Institute 1640 Medium (RMPI 1640 medium, 218 
GlutaMAXTM Supplement) containing 10% Fetal Bovine Serum, 100 U/mL penicillin G and 100 μg/mL 219 
streptomycin. Cells were seeded in 96 well microplates at a density of 103 cell/well and incubated at 37 °C 220 
in a humidified incubator. 221 
2.5.2. NO levels 222 
Nitrite content in culture medium was measured as an indicator of nitric oxide (NO) production. Nitrites 223 
were measured at 24 h after the addition of different concentration of RT extract (23, 47 or 93 µg/mL) and 224 
LPS (1 µg/ml) for 30 minutes. The same volume of supernatant and the Griess reagent (1% sulfanilamide 225 
in 5% phosphoric acid and 0.1% naphthylethylenediamine dihydrochloride in distilled water) were mixed 226 
during 10 minutes at room temperature and the absorbance at 570 nm was determined with a plate reader. 227 
2.5.3. TNF-α levels 228 
For determination of tumour necrosis factor-alpha (TNF-α) levels, cells were incubated with various 229 
concentrations of RT extract (23, 93 µg/mL) and LPS (1 µg/ml)-stimulated for 30 minutes. After 230 
centrifugation, the obtained supernatant was used to calculate the amount of TNF-α by a standard sandwich 231 
ELISA kit specific for murine cytokines (Cayman chemical®).  232 
2.6. In vivo assays 233 
2.6.1. Animals 234 
Male C57BL/6 mice (8-12 weeks) were purchased from Janvier (LeGenest St. Isle, France) and were 235 
allowed to acclimate for 1 week prior to the experiments. The animals were housed in plastic cages, 4-5 236 
mice/cage, under normal laboratory conditions (20 ± 2 °C, 40-60% relative humidity and normal light/dark-237 
cycle) with free access to standard chow and water.  238 
All the procedures of this study were performed in accordance with the ARRIVE guidelines and the Ethics 239 
Advisory Commission for Animal Experimentation of Universidad de Zaragoza (PI66/14, Spain). 240 
7 
 
2.6.2. Treatment, experimental colitis induction and tissue collection  241 
Animals were randomly divided into seven groups. i) control group (n=15); ii) RT50 group (n=8); iii) 242 
water+DSS group (n=15); iv) RT5+DSS group (n=4); v) RT25+DSS group (n=4); vi) RT50+DSS group 243 
(n=15) and vii) sulfasalazine (SSZ) + DSS group (n=12). All groups daily received 200 µL of water (control 244 
or water+DSS groups), RT extract (5, 25 or 50 mg/kg bw: RT5+DSS groups, RT25+DSS groups, RT50 or 245 
RT50+DSS groups) or SSZ (100 mg/kg bw) by oral gavage over a 20-day period according to Castro et al., 246 
2016 (Castro et al. 2016). The dose of SSZ has been chosen according to previous studies (Kim et al. 2014; 247 
Singh et al. 2009). RT and SSZ solutions were prepared daily. In order to avoid the undesirable effects of 248 
coprophagy, all the animals housed in each cage received the same treatment. 249 
An injury-repair colitis model was used (Whittem et al. 2010). At day 11, colitis was induced by switching 250 
to a 2.5% (w/v) solution of DSS (MW: 40,000 Da, Panreac, Lörrach, Germany) as drinking solution for 7 251 
days, followed by 3 days of autoclaved tap water for the recovery (Low et al. 2013). At day 20, all animals 252 
were sacrificed via cervical dislocation and the colon was removed for macroscopic study (Figure 3a). 253 
Terminal ileum was extracted and kept in cold Ringer Krebs (in mM: NaCl 120, KCl 4.70, CaCl2 2.40, 254 
MgSO4 1.20, NaHCO3 24.50, KH2PO4 1.00 and glucose 5.60; pH 7.4) for organ bath studies. Finally, 255 
samples of colon of control, RT50 group, water+DSS and RT50+DSS animals were kept for 256 
histopathological, immunofluorescence, myeloperoxidase (MPO), interleukins 6 and 10 (IL-6, IL-10), 257 
inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) studies. 258 
2.6.3. Colitis assessment 259 
A disease activity index (DAI) was used to assess the DSS-induced colitis symptomatology. DAI was 260 
calculated as the sum of the body weight score, which was the percentage of weight loss from the initial 261 
body weight on every day (0: < 1%, 1: 1-5%, 2: 5-10%. 3: 10–15%, 4: ≥15%), changes in stool consistency 262 
(0: normal, 1: loose stool, 4: water diarrhoea) and presence of faecal blood (0: normal, 2: occult bleeding, 263 
4: visible bleeding). The occult blood was measured with a stool blood test (Tri Slider FOB Guayaco, 264 
Sanilabo, Spain). 265 
2.6.4. Macroscopic study 266 
Colon length and thickness of the proximal and distal colonic wall were determined using a digital Vernier 267 
calliper (0.01 mm of resolution). Thereafter, the colon was cut-open longitudinally and washed with 0.9% 268 
saline solution. Colitis signs was graded according to a standard scoring system: Number of adhesions (0: 269 
0, 1: 1, 2: 2, 3: >2), diarrhoea (0: normal, 1: loose stool, 4: water diarrhoea), tumefaction (0: absence, 1: 270 
moderate, 2: severe), stenosis (0: 0, 1: 1, 2: 2, 3: >2), mucus (0: absence, 1: presence), haemorrhage (0: 271 
absence, 1: manifest bleeding), erythema (0: no macroscopic changes, 1: <1 cm, 2: ≥1 cm), ulcers or 272 
erosions (0: 0, 1: <1 cm, 2: ≥1 cm) and occult blood (0: no, 1: yes). A total macroscopic damage score was 273 
calculated for each animal.  274 
2.6.5. Recording of intestinal contractility  275 
Ileum was washed with Ringer Krebs, freed from adipose and connective tissues and cut in segments (10 276 
mm). The whole segments were suspended in the direction of longitudinal smooth muscle fibres in an organ 277 
bath in 5 mL of Ringer Krebs maintained at 37 °C and gassed with 95% O2-5% CO2. Intestinal contractility 278 
was recorded isotonically as in previous works of our laboratory (Valero et al. 2011).  279 
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After an adaptation period, spontaneous contractions of each group were registered and the effect on 280 
contractility of acetylcholine (ACh, 100 µM), a cholinergic agonist, was tested. To measure the irregularity 281 
of contractions the mean CV of each longitudinal contraction was estimated. During a period of 5 minutes, 282 
the mean of amplitude and frequency of spontaneous contractions were analysed. ACh-induced motor 283 
responses were measured as the area under the curve (AUC) during the first 3 min of ACh response and 284 
expressed as a percentage of control (3 min of the AUC area before addition of ACh). The AUC was 285 
normalized by the wet weight of each preparation. Results were expressed as a percentage of control group 286 
values (100%).  287 
Each experimental protocol was systematically made on one segment of ileum per mouse and was repeated 288 
on 4-10 animals. 289 
2.6.6. Histopathological study 290 
Pieces of proximal and distal colon were fixed in 10% buffered formalin (Panreac, Barcelona, Spain), then 291 
dehydrated, embedded in paraffin blocks, and cut into 4 μm-thick sections. They were stained with 292 
haematoxylin-eosin (HE). The analysis of these samples was performed by a pathologist by measuring the 293 
thickness of the intestinal mucosa in 5 different areas using a Nikon Eclipse Ci microscope, a Nikon DS-294 
Ri 1 digital still camera, and a Nikon NIS calibrated digital image analysis system. Histopathological 295 
analysis focused on normality or alteration of architecture and relative proportions of the structures, 296 
presence of abnormal vascularization, assessment of degenerative or necrotic features, degree of 297 
inflammation (cell infiltrates), and abnormal growth (atrophy, hyperplasia, hypertrophy and neoplasia).  298 
2.6.7. Determination of MPO activity 299 
Samples of distal colon stored at -80 °C were homogenized in 0.1 M phosphate buffer (pH 7.4) and then 300 
centrifuged at 15.000 rpm at 4 °C for 10 min, the supernatant fraction was used for the measurements of 301 
MPO content by the MPO activity Assay Kit (Sigma Aldrich). MPO activity was expressed as U/mg 302 
protein.  303 
2.6.8. Determination of IL-6 and IL-10 304 
Levels of IL-6 and IL-10, pro- and anti-inflammatory interleukins, respectively, were measured in colon 305 
homogenates (1:5 dilution) and samples of cells (1:2 dilution) using ELISA kits (KIT Ready-Set-Go!, 306 
eBioscience) as per the manufacturer's instructions. 307 
2.6.9. Protein extraction and Western blot analysis for determination of iNOS and COX-2 308 
Samples of distal colon were homogenized in cold lysis buffer containing 150 mM NaCl, 10 mM Tris pH 309 
7.5 and 1% Triton X-100 supplemented with a complete EDTA-free protease inhibitor cocktail (Roche). 310 
The homogenates were centrifuged at 15.000 rpm at 4 °C for 20 min, and the protein concentration of the 311 
supernatants was assessed using a Pierce BCA Protein Assay Kit (Thermo-Fisher). 312 
Proteins were separated on 7.5% SDS–PAGE gels (Bio-Rad) and transferred onto PVDF membranes 313 
(Immobilon-P; Millipore). The membranes were blocked with 5% non-fat milk in Tris buffered saline 314 
supplemented with 0.1% Tween-20 (TBST) at room temperature during 2h. After that, membranes were 315 
incubated with primary antibodies for iNOS (1:200, BD Biosciences), COX-2 (1:1000, BD Biosciences) 316 
and β-actin (1:5000, Santa Cruz Biotechnology, as loading control) overnight in TBST with 1% non-fat 317 
milk at 4 °C. Membranes were then washed and incubated with peroxidase-conjugated secondary antibodies 318 
in TBST with 1% non-fat milk for 2h at room temperature. The immunocomplexes were detected by a 319 
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chemiluminescent reaction using a Western Bright Sirius (Advansta) kit and the signal was visualized in 320 
VersaDoc (Bio-Rad). Results were expressed as iNOS/actin or COX-2/actin ratios in arbitrary 321 
densitometric units. 322 
2.6.10. Immunofluorescence and confocal microscopy 323 
Proximal colon sections were deparaffinised through Histo-Clear (National Diagnostics), and rehydrated in 324 
decreasing concentrations of ethanol and rinsed with distilled water and Tris buffered saline (TBS; 65 mM 325 
Tris-Cl, pH 7.5; 150 mM NaCl). Tissues were treated for 30 minutes with sodium borohydride (NaBH4; 326 
1% w/v) in ice-cold TBS to reduce auto-fluorescence. Non-specific binding was blocked with 1% BSA and 327 
0.5% Triton X100 in TBS (blocking buffer) for 3x10 minutes. Then, slices were incubated at 4 °C overnight 328 
with a goat anti-ZO-1 antibody (1:50, Santa Cruz Biotechnology). The next day, sections were washed with 329 
blocking buffer (3x10 minutes) and incubated with a donkey anti-goat IgG-AlexaFluor 488 secondary 330 
antibody (1:2000, Molecular Probes) in darkness for 2 h at room temperature. After 3 washes for 15 minutes 331 
each in TBS, preparations were mounted with Fluoromount-G (SouthernBiotech) containing 0.1% DAPI 332 
(Life Biotechnologies) and 0.4% DraQ5 (BioStatus) for DNA staining, and visualized under a confocal 333 
microscope (Olympus FV10). The images were acquired using the Olympus FV10-ASW 3.0 viewer 334 
software and further processed with ImageJ. 335 
2.7. Statistical analysis 336 
Data are expressed as mean ± SEM, and differences between groups were statistically analysed using the 337 
GraphPad Prism Software v6. One-way analysis of variance (ANOVA) followed by Tukey’s (when 338 
parametric distribution is observed), Kruskal Wallis tests (non parametric) or unpaired t-tests were used to 339 
detect differences. Parameters of spontaneous contractions (amplitude and frequency) were analysed as 340 
previously described on duodenum segments (Fagundes et al. 2007). Significance level was set to p < 0.05. 341 
 342 
3. Results 343 
3.1. Phytochemical analysis 344 
3.1.1. Phenolic compounds 345 
The HPLC-DAD analysis of the extract revealed the presence of fifteen phenolic compounds, including ten 346 
phenolic acids (1-9, 12) and five flavonols (10, 11, 13, 14 and 15) (Figure 1a). The ethanolic extract herein 347 
studied showed a high content of phenolic compounds (134.4 mg/g of dry extract) (Table 1). Representing 348 
more than 70% of all phenolics quantified, the hydroxycinnamic acids derived from caffeoylquinic acid 349 
were the dominant compounds in the extract, the pair 3,4-di-O-caffeoylquinic and 3,5-di-O-caffeoylquinic 350 
acids (7+8) being dominant (40.95 mg/g of dry extract), followed by 1,5-di-O-caffeoylquinic (9) and 4,5-351 
di-O-caffeoylquinic (12) acids (24.73 and 23.14 mg/g of dry extract, respectively) (Table 1). The flavonol 352 
quercetin-3-O-galactoside (10) was the fourth most representative compound in the extract (15.16 mg/g of 353 
dry extract) and the most abundant flavonoid found. 354 
3.1.2. Pigments 355 
The analytical methodology employed allowed the determination, for the first time, of two carotenoids, 356 
comprising one xanthophyll, lutein (17), and β-carotene (23), as well as of chlorophyll b (6), the chlorophyll 357 
a demetalation derivative pheophytin a (22), and compounds with chlorophyll a-like UV-vis spectrum, 358 
labelled as chlorophyll a derivatives (20 and 21). Two other compounds (compounds 18 and 19) were also 359 
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found; although their identity is not known, their chromatographic behaviour and UV-vis spectra allow 360 
classifying them as xanthophylls (Figure 1b). Among the carotenoids and chlorophylls quantified in our 361 
study, lutein (17) was the most representative, being its content higher than 55% of total pigments (Table 362 
1). 363 
3.2. Antioxidant potential in cell-free assays  364 
RT extract showed an effective and dose-dependent antioxidant effect against O2•- radicals generated by 365 
X/XO system, presenting an IC50 of 36.7 μg/mL. An IC50 value of 0.46 μg/mL was obtained for gallic acid, 366 
the positive control tested under the same conditions (Figure 2a).  367 
Moreover, RT extract, at higher doses, was also able to inhibit the xanthine oxidase enzyme responsible for 368 
this reaction, with an IC50 value of 929.86 μg/mL (Figure 2b).  369 
The capacity of the RT extract to scavenge superoxide radical generated by a non-enzymatic system was 370 
confirmed when this radical was generated by a chemical system, which indicated an IC50 of 47.0 μg/mL 371 
(Figure 2c). An IC50 value of 10.97 ± 0.68 μg/mL was obtained with quercetin, the positive control tested 372 
under the same conditions. This fact allows to conclude that the superoxide scavenging properties are 373 
independent to xanthine-oxidase inhibition. 374 
3.3. Anti-inflammatory activity 375 
RT extract also inhibited 5-LOX, showing an IC50 of 74.0 μg/mL (Figure 2d). An IC50 value of 3.29 ± 0.21 376 
μg/mL was obtained for quercetin, the positive control tested under the same conditions. 377 
LPS (1 µg/mL) increased the nitrite production and TNF-α expression in murine macrophages compared 378 
with control. RT extract presented a significant capacity to reduce to basal levels both NO production as 379 
well as the expression of the pro-inflammatory cytokine TNF-α in LPS-stimulated J774.2 macrophages 380 
(Figure 2e and 2f). These results confirmed the anti-inflammatory potential of RT extract. 381 
3.4. Protective effects of the RT extract on the development and recovery of DSS-induced colitis. 382 
RT per se did not affect clinical state of animals, as shown in Figure 3b. Colitis was manifested by weight 383 
loss, presence of blood in faeces, and changes in stool consistency. The DAI scores in Figure 3b showed 384 
that the RT extract, to different doses, delayed the appearance of colitis symptoms. However, at longer 385 
DSS-exposure (≥4 days), this protective effect vanished. Yet, the RT extract improved symptoms during 386 
the recovery phase of the animals. Thus, total disease severity was found to be lower in mice treated with 387 
RT extract vs. untreated colitic animals. SSZ, used as standard treatment of UC, was also effective in the 388 
initial phase, although less than RT (Figure 3b and 3c). In contrast to RT, SSZ did not improve disease 389 
severity in the recovery period (day 20) (Figure 3c).  390 
3.5. RT extract attenuates macroscopic colon damage in DSS-induced acute colitis. 391 
DSS administration reduced colonic length in all groups (Figure 4a). Administration of RT50 extract but not 392 
the reference drug SSZ significantly attenuated this effect. Also, wall thickness was increased in both 393 
proximal and distal colon after DSS. RT, dose-dependently, and SSZ mitigated this effect (Figure 4c and 394 
4d), although only reached statistical significance the effect of SSZ in proximal colon. Finally, DSS-395 
induced macroscopic damage, as seen in Figure 4b, was partially reversed by the RT extracts and SSZ. The 396 
administration of RT extract in animals that were not challenged with DSS did not produce any pathological 397 
alterations suggesting that the RT is not toxic at the dosage used here (Figure 4a-d). 398 
3.6. Functional studies of ileal contractility 399 
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Figure 5a shows the typical spontaneous contractile activity of longitudinal muscle segments of ileum 400 
isolated from different groups (control, RT50, water+DSS, RT5+DSS, RT25+DSS, and RT50+DSS group). 401 
RT50 extract per se did not change motility pattern. As expected, DSS severely impaired spontaneous 402 
contractions. Thus, as shown in Figure 5b, the longitudinal smooth muscle contractions were highly 403 
irregular and intermittent over time. In contrast, spontaneous contractions of the ileum segments from the 404 
RT-treated animals showed dose-dependent improvement of rhythm, being very similar to control with the 405 
higher doses of the plant (p=0.0095 water+DSS vs. RT25+DSS and p=0.0061 water+DSS vs. RT50+, in a 406 
Mann-Whitney test). Figure 5c shows that the DSS treatment also significantly decreased the amplitude of 407 
spontaneous contractions if compared to control, except for RT50+DSS-treated animals (p=0.0016 408 
water+DSS vs. RT50+DSS, Mann-Whitney test). The DSS treatment mildly reduced the frequency of ileal 409 
spontaneous contractions but the difference did not reach statistical significance (Figure 5d).  410 
The DSS treatment significantly decreased the contractions to ACh. Again, RT extract at higher but not 411 
lower doses prevented this effect (Figure 5e). Taken together, these results show that the RT treatment, in 412 
a dose dependent way, was able to ameliorate DSS effects on ileal motility and contractile capacity.  413 
The highest dose of RT was chosen for the rest of experiments due to its better effects on the clinical 414 
symptomatology, tissue damage, and functional studies. 415 
3.7. RT extract ameliorates histopathological alterations in DSS-induced colitis. 416 
Colon sections of DSS-treated animals showed severe colitis with massive destruction of the intestinal 417 
mucosa and severe infiltration of inflammatory cells into the lamina propria, especially in the distal colon 418 
(Figure 4f). In contrast, DSS-induced damage and inflammation was significantly lower in the distal colon 419 
in RT50-treated animals (Figure 4g), while the damage in the proximal colon was similar. The controls and 420 
the RT50-treated animals showed a typical colon structure, with normal sized intestinal villi, a normal lamina 421 
propria and submucosa with mild cell infiltrates (Figure 4e and 4h).  422 
3.8. Biochemical markers of inflammation (MPO, IL-6, IL-10, iNOS, COX-2) in colonic tissue 423 
MPO activity and IL-6 levels were significantly higher in colonic tissues of the DSS group than in controls. 424 
RT50 extract significantly reduced the DSS effect (Figure 6a and 6b). Colon of animals treated with DSS 425 
showed a decrease in the levels of IL-10 respect to controls (p = 0.057), an effect that was not prevented by 426 
the treatment with RT50 extract (Figure 6c). 427 
The effect of RT on inflammation was also studied by assessing the protein expression of iNOS and COX-428 
2. As shown in Figure 6d and 6e, as expected, the expression levels of iNOS and COX-2 were significantly 429 
increased in colonic tissues of DSS group respect to control. RT50 extract did not induce per se expression 430 
of COX-2 or iNOS but it significantly prevented the induction of these enzymes by DSS. 431 
3.9. RT extract prevents DSS-induced loss of ZO-1. 432 
ZO-1, a tight junction protein of the intestinal epithelial barrier, was visualized by immunofluorescence / 433 
confocal microscopy in colon samples of control, water+DSS and RT50+DSS groups. 434 
As shown in Figure 6a, ZO-1 was mainly expressed at the apical border of the lining epithelium in control 435 
animals. Furthermore, a dotted-spherical pattern of expression, likely cytoplasmic, was also observed 436 
deeper in the tissue (Figure 7a). In contrast, in 3 out of 3 DSS mice apical ZO-1 expression was lost, while 437 
the dotted-spherical expression was preserved (Figure 7b). The treatment with RT50 extract prevented the 438 
loss of apical ZO-1 in the lining epithelium of DSS-challenged animals in 3 out of 3 animals (Figure 7c). 439 
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 440 
4. Discussion 441 
This study characterized phytochemically an ethanolic extract of RT and investigated its ability to improve 442 
experimental DSS-induced colitis in mice by using a wide range of cell-free, cell-based, in-vivo and ex-vivo 443 
techniques. Data demonstrate that RT was capable of ameliorating clinical symptoms of colitis in this 444 
model, i.e., weight loss, loose and bloody stool, inflammation, damage of the colon mucosa, including the 445 
preservation of the intestinal barrier. Moreover, the extract has been shown to normalize the severely 446 
impaired ileal contractility observed in this model. Anti-inflammatory and antioxidant effects have also 447 
been detected, which could explain the observed in-vivo benefits. It is the first time that a study provides 448 
experimental proof for the utility of Jasonia glutinosa as herbal medicine or herbal supplement in UC.  449 
 450 
RT extract is rich in polyphenols that are well-known antioxidant agents. Some of them have been described 451 
to possess in-vitro anti-inflammatory activities (Hussain et al. 2016). A recent study simulating an in vitro 452 
digestion showed that digestive processes may alter the composition of Jasonia glutinosa extracts (Ortega-453 
Vidal et al. 2019); however, our extract preserved its anti-inflammatory properties both in in vitro and in 454 
vivo assays. 455 
RT extract showed a rich and varied phenolic profile, composed of flavonols and hydroxycinnamic acids, 456 
predominantly caffeoylquinic acids (Figure 1a, Table 1). Previous phytochemical studies have shown the 457 
presence of flavonoids, like quercetin, kaempferol derivatives and phenolic acids in methanolic and 458 
aqueous extract of RT (Ortega-Vidal et al. 2019; Rubio et al. 1995; Valero et al. 2013).  We here show that 459 
ethanolic extract is also rich in phenolic acids, in particular caffeoylquinic acids, and pigments, which could 460 
be of interests for industrial purposes as ethanol (instead of methanol as solvent) is permitted and used in 461 
pharmaceutical products. Other studies have found kaempferol in RT extracts, as well as some glycosides 462 
of quercetin, such as quercetin-3-O-rhamnoside, quercetin-3-O-rutinoside. Oral administration of high 463 
amounts of isolated flavonoids also showed beneficial effects on DSS-induced colitis in mice as they 464 
prevented weight loss, histological alterations and inflammation caused by colitis (Brückner et al. 2012; 465 
Camuesco et al. 2004; Comalada et al. 2005; Park et al. 2012). Probably, these actions could be mediated 466 
through down-regulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), that 467 
results in a reduction of pro-inflammatory cytokines as IL-6, IL-1β and TNF-α, iNOS expression and NO 468 
levels, LOX and COX-2 expression, prostaglandin E2 levels and MPO activity (Brückner et al. 2012; 469 
Camuesco et al. 2004; Comalada et al. 2005; Liu et al. 2014; Park et al. 2012).  470 
Concerning caffeoylquinic acids found in our RT extract, it is worth mentioning that esters formed by 471 
caffeic and quinic acids (caffeoylquinic acids), represent an abundant group of plant polyphenols present 472 
in human diet and their role in controlling oxidative and inflammatory stress conditions is reviewed in 473 
previous works (Liang and Kitts 2015). The anti-ulcerogenic properties of some caffeoylquinic acids, such 474 
as 5-O-caffeoylquinic, 3,4-di-O-caffeoylquinic and 3,5-di-O-caffeoylquinic acids has already been 475 
documented (Lee et al. 2010). In several animal studies, the oral administration of 5-O-caffeoylquinic acid 476 
showed protective effects in different induced-colitis models, by reducing neutrophil infiltration and 477 
inhibition of the NF-κB pathway (Liang and Kitts 2015) and by promoting growth of Akkermansia in mice 478 
(Zhang et al. 2017).  479 
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 480 
Carotenoids represent the most abundant lipid-soluble phytochemicals, and in-vitro and in-vivo studies have 481 
suggested their antioxidant and anti-inflammatory properties (Kaulmann and Bohn 2014). The problems 482 
observed in the digestion and absorption of fat-soluble compounds in patients with IBD could delay their 483 
protective effects, as they are described against colon related diseases, such as cancer, Crohn disease and 484 
UC (Slattery et al. 2000).  485 
 486 
Two biologically important carotenoids were found in our RT extract, lutein (17) and β-carotene (23). 487 
Glabska and colleagues reported that a higher intake of a mixture of lutein and zeaxanthin (ca. 1800 µg) 488 
was associated with the reduction of faecal blood, mucus and pus in individuals with UC (Głąbska et al. 489 
2016), and with lower incidence of constipation in individuals with UC in remission phase (Głąbska et al. 490 
2019). Likewise, β-carotene (at doses of 5-50 µM) was described to ameliorate UC-associated local and 491 
systemic damage in mice, by acting on multiple targets (Kaulmann and Bohn 2014; Trivedi and Jena 2015). 492 
RT extract presented a lutein content (ca. 148 µg/g) almost eight times higher than that of β-carotene (ca. 493 
20 µg/g) (Table 1). Although in the work herein a daily content of 50 mg RT of extract/kg bw was 494 
administrated to the animals and, at this doses, the concentration of lutein and β-carotene (ca. 7.4 µg and 1 495 
ng, respectively) were much lower than those showing therapeutic efficacy (Głąbska et al. 2019; Głąbska 496 
et al. 2016; Kaulmann and Bohn 2014; Trivedi and Jena 2015), the possibility of contribution of these 497 
compounds as themselves, as well as of the synergic effects between them, cannot be ignored. 498 
 499 
Concerning the underlying mechanisms by which RT shows therapeutic efficacy in DSS-induced colitis, 500 
our in-vitro studies revealed that RT extract strongly scavenged superoxide radicals using the X/XO system. 501 
However, when using this assay, we cannot fully exclude a direct inhibitory effect on the enzyme itself. 502 
Indeed, we found that the extract presented a low XO inhibitory activity (IC50 = 929.86 μg/mL). Still, when 503 
the extract was tested in the NADH/PMS system, we found a clear-cut O2•- scavenging effect.  504 
Respecting the anti-inflammatory properties of RT in the DSS model, we found that RT inhibited 5-LOX-505 
activity, which is known to be required for the synthesis of pro-inflammatory molecules, i.e. leukotrienes. 506 
Among several isoforms, 5-LOX is one of the most important in physiological and pathological processes 507 
(Rådmark et al. 2015) and LOX-inhibitors have been found in plant extracts (Schneider and Bucar 2005). 508 
Therefore, the lower degree of inflammation in RT-treated mice can be explained through 5-LOX inhibiting 509 
properties. In addition, RT extract reduced the production of NO and TNF-α induced by LPS in J774.2 510 
macrophages. In colonic tissue, RT extract decreased MPO activity, the rise in IL-6 levels as well as in 511 
COX-2 and iNOS expression. On the other hand, RT extract had no effect on IL-10 levels. Together, these 512 
findings suggest that RT has potent and multifaceted anti-inflammatory properties involving several signal 513 
pathways and cell systems. Interestingly, this anti-inflammatory profile shares similarities with anti-514 
inflammatory properties of other medicinal plant compounds, such as corilagin, a TGFβ1-inhibiting 515 
molecule (Xiao et al. 2013).  516 
 517 
Our immune histological studies suggest that the efficacy of this extract also relied on maintaining the 518 
integrity of intestinal barrier intact, as concluded from the conserved ZO-1 expression at enterocytes tight 519 
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junctions. Intact functioning of tight junctions is essential for building the intestinal barrier (Mankertz and 520 
Schulzke 2007; Poritz et al. 2007). In addition, it is well known that cytokines regulate tight junctions 521 
(Capaldo and Nusrat 2009) and, particularly, TNFα and IL-6 have been reported to impair intestinal barrier 522 
by interfering with ZO-1 protein expression and localization (Desai et al. 2002; Ma et al. 2004). The 523 
protective effect of RT on the intestinal barrier may therefore be explained by RT’s ability to prevent TNFα 524 
and IL-6 induction.  525 
 526 
Regarding appearance and progressive aggravation of clinical symptoms, RT was also effective. However, 527 
this therapeutic effect was seen during the first three days of the DSS treatment but not during the next four 528 
days. Additionally, RT significantly promoted recovery after cessation of the inflammatory stimulus. If 529 
compared this efficacy with that of a standard anti-inflammatory treatment for UC, i.e. SSZ, RT showed 530 
similar or even better efficacy considering that RT but not SSZ delayed the development of severe 531 
symptomatology and promoted recovery. At the anatomical/histological level, RT extract prevented to a 532 
considerable extent the reduction of colonic length and the increase in the wall thickness that are typical 533 
features of this DSS model. It is worth mentioning that studies testing green tea polyphenols (Oz et al. 534 
2013) or foods rich in polyphenols (Kang et al. 2017; Kim et al. 2014; Singh et al. 2009) and also using 535 
SSZ as standard treatment in this colitis model, showed comparable therapeutic efficacy. 536 
 537 
Besides morphological and histological changes, it is known that DSS impairs motility in the colon and, 538 
more recently, also in the small intestine (Lykov et al. 2018; Yazbeck et al. 2011). Here, we provide 539 
additional evidence for this harmful impact of DSS on ileal contractility by showing un-coordinated and 540 
weaker spontaneous contractions and weaker ACh-induced responses. Importantly, we show that RT, in a 541 
dose dependent manner, was also capable of preventing this alteration. Thus, RT50-treated mice exhibited 542 
coordinated rhythmic spontaneous motility and conserved amplitude of contractions. This findings are also 543 
in line with our previous work showing that RT at 50 mg/kg normalized whole gastrointestinal transit in 544 
this model of colitis (Castro et al. 2016). This protective effect of RT on ileal motor function may be due 545 
to a decrease on local inflammatory mediators as shown with other vegetal extracts (Chaudhuri et al. 2000). 546 
This beneficial effect on intestinal motility is likely the functional outcome of RT´s complex anti-547 
inflammatory, antioxidant and tissue-protective effects.  548 
 549 
5. Conclusions 550 
In summary, this work provides evidence that RT extract has beneficial effects in a DSS-induced colitis 551 
model, improving clinical symptoms, attenuating tissue damage, preserving the intestinal barrier and 552 
normalizing the intestinal contractility. The benefits of RT extract could be related to its biologically-553 
relevant chemical composition. We suggest that RT may be of potential therapeutic utility in UC and other 554 
inflammatory bowel diseases.  555 
 556 
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Figure captions 732 
 733 
Figure 1. Representative HPLC-DAD chromatogram of the (a) phenolic compounds and (b) pigment 734 
profiles of J. glutinosa extract. Detection at 320 and 450 nm, respectively. (1) 3-O-caffeoylquinic acid; (2) 735 
5-O-caffeoylquinic acid; (3) 4-O-caffeoylquinic acid; (4) caffeic acid; (5) 1,3-di-O-caffeoylquinic acid; (6) 736 
Isoferulic acid; (7) 3,4-di-O-caffeoylquinic acid; (8) 3,5-di-O-caffeoylquinic acid; (9) 1,5-di-O-737 
caffeoylquinic acid; (10) quercetin-3-O-galactoside; (11) quercetin-3-O-glucoside; (12) 4,5-di-O-738 
caffeoylquinic acid; (13) quercetin; (14) kaempferol; (15) isorhamnetin; (16) chlorophyll b; (17) lutein; (18 739 
and 19) unidentified xanthophylls; (20 and 21) chlorophyll a derivatives; (22) pheophytin a; (23) β-740 
carotene. 741 
 742 
Figure 2. Antioxidant activities and anti-inflammatory effect in cell-free and cell-based assays. a) 743 
Antioxidant activity of RT extract and gallic acid against superoxide radicals generated by the 744 
xanthine/xanthine oxidase method. b) Xanthine oxidase inhibition by RT extract. c) Effect of J. glutinosa 745 
extract against O2●- generated by the NADH/PMS system. d) Enzymatic inhibition of J. glutinosa extract 746 
towards 5-LOX. e) Effect of RT extract on production of nitrate concentration in LPS-stimulated cells (1 747 
µg/ml). f) Inhibitory effect of RT in TNF-α expression in LPS-stimulated cells (1 µg/ml). Results show 748 
mean ± SEM of four or six experiments, each performed in triplicate. **P<0.001 vs. control group, #P<0.05 749 
vs. LPS in absence of RT.   750 
 751 
Figure 3. Induction and symptomatology of colitis. a) Experimental design of the induction of colitis by 752 
DSS administration for 7 days. Mice were daily treated with either RT extract (5, 25 or 50 mg/kg bw, p.o.), 753 
sulfasalazine (SSZ, 100 mg/kg bw), or vehicle over 20 days. From day 11 to day 17, mice received 2.5% 754 
dextran-sodium sulphate (DSS). At day 18, the drinking water with DSS was removed and three days of 755 
recovery were evaluated. b) The DAI score was assessed daily in all groups. Data are presented as mean ± 756 
SEM (n=4-15). *P<0.05, ***P<0.001 water+DSS group vs. control and RT50 groups; &P<0.05 RT5+DSS 757 
group vs control and RT50 groups; $P<0.05 RT25+DSS group vs control and RT50 groups; ##P<0.01, 758 
###P<0.001 RT50+DSS group vs control and RT50 groups; πP<0.05, πππP<0.001 SSZ+DSS group vs. control 759 
and RT50 groups. c) Comparison of the protective effect against colitis between RT50 and SSZ. Data are 760 
presented as mean ± SEM (n=8-15). *P<0.05, **P<0.01 RT50+DSS group vs. water+DSS group; εεP<0.01 761 
RT50+DSS vs. SSZ+DSS group.  762 
 763 
Figure 4. Beneficial effects of RT extract on macroscopic and histopathological changes in the colon. a) 764 
Colon length. b) Macroscopic damage score. c) Proximal colon thickness. d) Distal colon thickness. Data 765 
are presented as mean ± SEM (n=4-15). *P<0.05, ***P<0.001 vs. control group; #P<0.05, ##P<0.01, 766 
###P<0.001 vs. RT50 group; &P<0.05, &&P<0.01 vs. water+DSS group. e-h) Images of HE staining of distal 767 
colon on different groups: e) control group, f) water+DSS group, g) RT50+DSS group, h) RT50 group (n=4). 768 
Scale bars represent 50 µm (e, h) or 100 µm (f, g). 769 
 770 
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Figure 5. Effects of RT extracts on alterations in intestinal contractility observed in colitis. a) Recordings 771 
of spontaneous contractions from longitudinal smooth muscle of mice ileum in different groups. b) Mean 772 
coefficient of variation of each longitudinal contraction in the ileum. c) Percentage of amplitude and d) 773 
frequency on spontaneous contractions. e) Effect of ACh (100 µM) on spontaneous contractions. Data are 774 
expressed as mean ± S.E.M. Segments obtained from 4-10 mice. *p<0.05 vs. control; #p<0.05 and ##p<0.01 775 
vs. RT50 group 776 
 777 
Figure 6. RT extract attenuates the inflammation and oxidant effect of DSS in colon from colitic mice. a) 778 
Colonic MPO activity, b) IL-6 levels and c) IL-10 levels in DSS-induced colitis. Representative western 779 
blots and quantitative analysis of d) iNOS protein and e) COX-2 protein. Data are presented as mean ± 780 
SEM (n=6-8). *P<0.05, **P<0.01 vs. control group; &P<0.05, &&P<0.01 vs. water+DSS group. 781 
 782 
Figure 7. Effect of RT extract on the expression of the tight junction protein ZO-1. Representative confocal 783 
images (n=3) on a) control group, b) water+DSS group and c) RT50+DSS group. In control mice (a), ZO-1 784 
was expressed at the luminal part of the epithelium (arrows) but an inner spherical staining was also 785 
observed (arrowheads). DSS decreased apical expression, effect reverted by RT50 extract administration.  786 
M: mucosa. L: lumen.  787 
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Table 1. Phenolics and pigments content of J. glutinosa extract (mg/g dry extract)a 788 
Peak Compound 
Regression 
equation 
(µg/mL) 
r2 
Linearity 
(µg/mL) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
Precision 
J. glutinosa 
(mg/g, dry extract) Inter-days 
(CV, %) 
Intra-day 
(CV, %) 
PHENOLIC COMPOUNDS         
 Phenolic acids         
1 3-O-Caffeoylquinic acid y = 2.063×106x 0.9991 1.875-120.0 0.3230 0.9798 8.641 3.486 0.9168 ± 0.07921   
2 5-O-Caffeoylquinic acid y = 2.223×106x 0.9994 0.2716-198.0 0.03256 0.09867 6.375 1.035 12.32 ± 0.7855 
3 4-O-Caffeoylquinic acid y = 2.116×106x 0.9994 1.781-114.0 0.07630 0.2312 7.764 2.876 0.6678 ± 0.05185 
4 Caffeic acid - - - - - - - nq 
5 1,3-di-O-caffeoylquinic acid y = 2.548×106x 0.9995 0.4453-114.0 0.05592 0.1695 10.13 1.518 0.5198 ± 0.05263 
6 Isoferulic acid y = 3.921×106x 0.9994 0.4296-110.0 0.03260 0.09888 10.06 7.057 0.7829 ± 0.07876 
7+8 3,4-di-O-caffeoylquinic acid + 3,5-di-O-caffeoylquinic acidb y = 2.455×10
6x 0.9973 0.4805-246.0 0.03829 0.1160 6.418 7.527 40.95 ± 2.628 
9 1,5-di-O-caffeoylquinic acid y = 2.799×106x 0.9999 0.4375-112.0 0.1322 0.4006 9.888 2.682 24.73 ± 2.445 
12 4,5-di-O-caffeoylquinic acid y = 2.537×106x 1.000 0.4531-116.0 0.2527 0.7659 10.88 6.630 23.14 ± 2.516 
 Flavonoids         
10 Quercetin-3-O-galactoside y = 1.832×106x 0.9987 0.2908-212.0 0.08140 0.2467 8.219 1.695 15.16 ± 1.246 
11 Quercetin-3-O-glucoside y = 1.878×106x 0.9992 0.07520-154.0 0.07796 0.2362 4.525 2.202 7.716 ± 0.3491 
13 Quercetin y = 1.907×106x 0.9995 0.1387-124.0 0.08139 0.2466 8.149 1.189 5.015 ± 0.4087 
14 Kaempferol y = 1.941×106x 0.9994 1.859-119.0 0.5339 1.6177 9.275 3.920 0.5244 ± 0.04864 
15 Isorhamnetin y = 6.322×105x 0.9999 1.025-262.5 0.2252 0.6826 9.979 3.916 1.983 ± 0.2280 
 Total phenolics        134.4 ± 10.92 
 789 
Table 2. (continued) 790 
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Peak Compound 
Regression 
equation 
(µg/mL) 
r2 
Linearity 
(µg/mL) 
LOD 
(µg/mL) 
LOQ 
(µg/mL) 
Precision 
J. glutinosa 
(mg/g, dry extract) 
Inter-
days 
(CV, %) 
Intra-day 
(CV, %) 
PIGMENTS         
 Carotenoids         
17 Lutein y = 2.492×102x 0.9992 
0.07813-
10.00 0.003416 0.01035 5.619 4.849 0.1477 ± 0.008299 
23 β-carotene y = 6.713×102x 1.000 
0.2743-
66.67 0.03475 0.1053 9.129 5.548 0.01953 ± 0.001783 
 Chlorophylls         
16 Chlorophyll b y = 9.459×101x 0.9998 
0.5208-
8.333 0.1027 0.3113 8.263 5.232 0.09917 ± 0.008194 
 Total pigments        0.2664 ± 0.01828 
a Results are expressed as the mean ± standard deviation of six determinations. LOD – limit of detection. LOQ – limit of quantification. b Quantified together as 3,5-791 
dicaffeoylquinic acid. “nq” – not quantified 792 
